- Home
- DTSQ vs KYTX Comparison
DTSQ vs KYTX Comparison
Compare DTSQ & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSQ
- KYTX
- Stock Information
- Founded
- DTSQ 2022
- KYTX 2018
- Country
- DTSQ United States
- KYTX United States
- Employees
- DTSQ N/A
- KYTX N/A
- Industry
- DTSQ
- KYTX
- Sector
- DTSQ
- KYTX
- Exchange
- DTSQ NYSE
- KYTX NYSE
- Market Cap
- DTSQ 91.7M
- KYTX 92.1M
- IPO Year
- DTSQ 2024
- KYTX 2024
- Fundamental
- Price
- DTSQ $10.32
- KYTX $2.55
- Analyst Decision
- DTSQ
- KYTX Strong Buy
- Analyst Count
- DTSQ 0
- KYTX 5
- Target Price
- DTSQ N/A
- KYTX $19.00
- AVG Volume (30 Days)
- DTSQ 3.3K
- KYTX 382.4K
- Earning Date
- DTSQ 01-01-0001
- KYTX 05-13-2025
- Dividend Yield
- DTSQ N/A
- KYTX N/A
- EPS Growth
- DTSQ N/A
- KYTX N/A
- EPS
- DTSQ 0.28
- KYTX N/A
- Revenue
- DTSQ N/A
- KYTX N/A
- Revenue This Year
- DTSQ N/A
- KYTX N/A
- Revenue Next Year
- DTSQ N/A
- KYTX N/A
- P/E Ratio
- DTSQ $36.82
- KYTX N/A
- Revenue Growth
- DTSQ N/A
- KYTX N/A
- 52 Week Low
- DTSQ $9.96
- KYTX $1.78
- 52 Week High
- DTSQ $10.37
- KYTX $16.64
- Technical
- Relative Strength Index (RSI)
- DTSQ N/A
- KYTX 57.07
- Support Level
- DTSQ N/A
- KYTX $2.43
- Resistance Level
- DTSQ N/A
- KYTX $2.82
- Average True Range (ATR)
- DTSQ 0.00
- KYTX 0.23
- MACD
- DTSQ 0.00
- KYTX 0.04
- Stochastic Oscillator
- DTSQ 0.00
- KYTX 64.47
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.